{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T20:21:50Z","timestamp":1787516510404,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["COGEN25Y7"],"award-info":[{"award-number":["COGEN25Y7"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["008803D125 - Wyatt"],"award-info":[{"award-number":["008803D125 - Wyatt"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["MCGARRY23Y5"],"award-info":[{"award-number":["MCGARRY23Y5"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcf.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:34:55Z","timestamp":1787391295000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variants of varying clinical consequence (VVCCs) are associated with differing penetrance and expressivity in children with CRMS\/CFSPID"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9476-0788","authenticated-orcid":false,"given":"MacKenzie L.","family":"Wyatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Raraigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V","family":"Faino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"McGarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.08.004_bib0001","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2026.08.004_bib0002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijns11020024","article-title":"Cystic fibrosis newborn screening: a systematic review-driven consensus guideline from the united states cystic fibrosis foundation","volume":"11","author":"McGarry","year":"2025","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcf.2026.08.004_bib0003","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation","volume":"181","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.08.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.09.066","article-title":"Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome and cystic fibrosis screen positive, inconclusive diagnosis","volume":"181","author":"Ren","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.08.004_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114287","article-title":"Diagnostic transitions of cystic fibrosis and CRMS compared after 12 years of newborn screening in California","volume":"276","author":"Sciortino","year":"2025","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.08.004_bib0007","first-page":"46","article-title":"Biochemical and genetic Tools to predict the progression to cystic fibrosis in CRMS\/CFSPID subjects: a systematic review","volume":"51","author":"Terlizzi","year":"2024","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2026.08.004_bib0008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/ijns11030060","article-title":"Refining CFTR-related metabolic syndrome (CRMS)\/cystic fibrosis screen positive, inconclusive diagnosis (CFSPID) diagnosis: impact of CFTR2 variant classifications","volume":"11","author":"Wyatt","year":"2025","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcf.2026.08.004_bib0011","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jcf.2026.08.004_bib0012","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/381001","article-title":"Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign","volume":"74","author":"Groman","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcf.2026.08.004_bib0013","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jcf.2011.03.009","article-title":"Assessment of CFTR function in homozygous R117H-7T subjects","volume":"10","author":"de Nooijer","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.004_bib0014","doi-asserted-by":"crossref","first-page":"e1523","DOI":"10.1542\/peds.2005-3161","article-title":"Immunoreactive Trypsin\/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?","volume":"118","author":"Scotet","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2026.08.004_bib0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12887-019-1756-4","article-title":"Immunoreactive trypsinogen levels in newborn screened Infants with an inconclusive diagnosis of cystic fibrosis","volume":"19","author":"Ooi","year":"2019","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jcf.2026.08.004_bib0016","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcf.2021.03.015","article-title":"A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS\/CFSPID) in six Italian centres","volume":"20","author":"Terlizzi","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.004_bib0017","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-020-0822-5","article-title":"CFTR variant testing: a technical standard of the American college of medical genetics and genomics (ACMG)","volume":"22","author":"Deignan","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.jcf.2026.08.004_bib0018","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jcf.2022.12.002","article-title":"High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results","volume":"22","author":"Ginsburg","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.004_bib0019","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"ECFS neonatal screening working group cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): a new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-064657","article-title":"Cystic fibrosis foundation evidence-based guideline for the management of CRMS\/CFSPID","volume":"153","author":"Green","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2026.08.004_bib0021","first-page":"35","article-title":"Left behind: the potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis","volume":"42","author":"McGarry","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2026.08.004_bib0022","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ppul.26209","article-title":"Detection of disease-causing CFTR variants in state newborn screening programs","volume":"58","author":"McGarry","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.08.004_bib0023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcf.2022.07.010","article-title":"Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening","volume":"22","author":"McColley","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(15)30074-6","article-title":"WS11.6 newborn screening for cystic fibrosis: rationale for p.Arg117His (R117H) removal from the CFTR mutation panel in France","volume":"14","author":"Munck","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108582","article-title":"Cystic fibrosis newborn screening in a high prevalence population \u2013 ten years\u2019 experience in Ireland","volume":"251","author":"McGuire","year":"2026","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2026.08.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/jgc4.70151","article-title":"Developing a primer for communicating about penetrance, expressivity, and genotype-phenotype correlation of R117H and the poly-T Tract in CFTR","volume":"34","author":"Raraigh","year":"2025","journal-title":"J Genet Couns"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T19:44:17Z","timestamp":1787514257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326037185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"alternative-id":["S1569199326037185"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.08.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variants of varying clinical consequence (VVCCs) are associated with differing penetrance and expressivity in children with CRMS\/CFSPID","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}